Compugen Stock

Compugen FCF CAGR 5Y

The FCF CAGR (5 Year) of Compugen (CGEN) as of Aug 15, 2026 is 1.92 %.

FCF CAGR 5Y

1.92 %

Last updated:

FCF CAGR (5 Year) of Compugen is 2026 1.92 % . FCF CAGR (5 Year) of Compugen was 2025 0.00 . It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

FCF CAGR (5 Year) of Compugen is 1.92 % in 2026.

On Eulerpool you can find the complete historical development of FCF CAGR (5 Year) Compugen since 2006 – with annual values, charts, and detailed analysis.

The 5-year FCF CAGR shows the compound annual growth rate of free cash flow over five years.

To evaluate FCF CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF CAGR (5 Year).

FCF CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track FCF CAGR (5 Year)'s Compugen historically and in real time.

Access this data via the Eulerpool API

Growth — Compugen

All Key Metrics — Compugen